Year |
Citation |
Score |
2020 |
Han L, Korangath P, Nguyen NK, Diehl A, Cho S, Teo WW, Cope L, Gessler M, Romer L, Sukumar S. HEYL Regulates Neoangiogenesis Through Overexpression in Both Breast Tumor Epithelium and Endothelium. Frontiers in Oncology. 10: 581459. PMID 33520697 DOI: 10.3389/fonc.2020.581459 |
0.389 |
|
2016 |
Merino VF, Nguyen N, Jin K, Sadik H, Cho S, Korangath P, Han L, Foster YM, Zhou XC, Zhang Z, Connolly R, Stearns V, Ali SZ, Adams C, Chen Q, et al. Combined treatment with epigenetic, differentiating, and chemotherapeutic agents cooperatively targets tumor-initiating cells in triple negative breast cancer. Cancer Research. PMID 26787836 DOI: 10.1158/0008-5472.Can-15-1619 |
0.438 |
|
2015 |
Korangath P, Teo WW, Sadik H, Han L, Mori N, Huijts CM, Wildes F, Bharti S, Zhang Z, Santa-Maria CA, Tsai H, Dang CV, Stearns V, Bhujwalla ZM, Sukumar S. Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 3263-73. PMID 25813021 DOI: 10.1158/1078-0432.Ccr-14-1200 |
0.488 |
|
2014 |
Mi C, Shi H, Ma J, Han LZ, Lee JJ, Jin X. Celastrol induces the apoptosis of breast cancer cells and inhibits their invasion via downregulation of MMP-9. Oncology Reports. 32: 2527-32. PMID 25310109 DOI: 10.3892/or.2014.3535 |
0.369 |
|
2014 |
Han L, Diehl A, Nguyen NK, Korangath P, Teo W, Cho S, Kominsky S, Huso DL, Feigenbaum L, Rein A, Argani P, Landberg G, Gessler M, Sukumar S. The Notch pathway inhibits TGFβ signaling in breast cancer through HEYL-mediated crosstalk. Cancer Research. 74: 6509-18. PMID 25217524 DOI: 10.1158/0008-5472.CAN-14-0816 |
0.476 |
|
2012 |
Ordentlich P, Nguyen N, Jin K, Sadik H, Han L, Sukumar S. Abstract P2-09-01: Reactivation of epigenetically silenced retinoic acid receptor-beta for therapy of breast cancer- from molecular mechanism to potential clinical applications Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P2-09-01 |
0.42 |
|
2011 |
Han L. A new perspective on estrogen receptor beta in breast cancer progression Cancer Biology and Therapy. 11: 644-646. PMID 21307641 DOI: 10.4161/cbt.11.7.14983 |
0.372 |
|
2010 |
Lo PK, Lee JS, Liang X, Han L, Mori T, Fackler MJ, Sadik H, Argani P, Pandita TK, Sukumar S. Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer. Cancer Research. 70: 6047-58. PMID 20587515 DOI: 10.1158/0008-5472.Can-10-1576 |
0.503 |
|
Show low-probability matches. |